Placental IL-10 dysregulation and association with bronchopulmonary dysplasia risk

Elisabeth C McGowan1, Stefan Kostadinov, Kathryn McLean

  • 1Department of Pediatrics, Women and Infants Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island 02915, USA.

Pediatric Research
|July 8, 2009
PubMed

Insights

Bronchopulmonary dysplasia (BPD) in premature infants may be predicted by placental cytokine expression. Lower levels of anti-inflammatory interleukin-10 (IL-10) in the placenta are linked to BPD development, suggesting a protective role.

Area of Science:

  • Perinatology
  • Neonatology
  • Immunology

Background:

  • Premature infants often exhibit proinflammatory states, contributing to bronchopulmonary dysplasia (BPD) pathogenesis.
  • The placenta's role in initiating BPD events is under investigation.
  • Cytokine profiles in amniotic fluid, cord serum, and tracheal aspirates indicate a shift towards inflammation.

Purpose of the Study:

  • To investigate placental cytokine expression as a predictor of BPD in premature infants.
  • To determine if placental cytokine profiles reflect events leading to BPD development.
  • To analyze the association between specific cytokines (IL-6, IL-10) and BPD incidence.

Main Methods:

  • Retrospective, case-controlled study of 98 premature infants (49 with BPD, 49 without).
  • Matched infants by gender, birth weight, and year of birth.
  • Immunohistochemistry used to assess cytokine expression (IL-6, IL-10) in placental tissues, membrane rolls, and umbilical cords.

Main Results:

  • Interleukin-6 (IL-6) expression was similar in infants with and without BPD.
  • Anti-inflammatory interleukin-10 (IL-10) expression was significantly lower in the placentas of infants who developed BPD.
  • Reduced IL-10 expression in the villous trophoblast layer correlated with a significantly lower odds of developing BPD (adjusted OR 0.08).

Conclusions:

  • Placental cytokine balance, particularly involving IL-10, is critical for normal lung development in premature infants.
  • Lower placental IL-10 expression is associated with an increased risk of BPD.
  • IL-10 may play a protective role against the development of BPD.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...